CRI Lifetree Appoints Alicia Craig-Rodriguez and Jose Marcos to Leadership Team.
MOUNT LAUREL, N.J. -- CRI Lifetree, a leader in specialized, multitherapeutic early stage research has strengthened its early phase leadership with the appointments of Alicia (Ali) Craig-Rodriguez as Chief Operating Officer and Jose Marcos as East Coast Director of Clinical Operations.
Craig-Rodriguez has more than 25 years of leadership experience, including 15 years of overseeing the operational, regulatory and quality compliance of more than 1,000 clinical trials. She has led teams in the creation of comprehensive and industry-compliant SOPs, quality management programs and employee training. Prior to joining CRI Lifetree, Craig-Rodriguez served as president of Comprehensive Clinical Development.
"Craig-Rodriguez and Marcos bring strong backgrounds in early phase research and operation to our leadership team," said Jeff Kinell, CRI Lifetree's chief executive officer. "As chief operating officer, Craig-Rodriguez will play a key role in strengthening our core areas of inpatient and outpatient psychiatry, and will lead the company's strategic growth plan in the areas of pain, human abuse liability, psychiatry, neurology and diabetes."
Marcos will add experience to CRI Lifetree's leadership team with more than 18 years of hands-on Phase I expertise. Prior to joining CRI Lifetree, Marcos served as vice president of Phase I clinical operations at Comprehensive Clinical Development. During his tenure there, Marcos advanced the operating infrastructure from a single, 36-bed unit to include three state-of-the-art facilities with a bed capacity exceeding 400 beds.
"As our regional director of clinical operations on the East Coast, Marcos will support our leadership team in the day-to-day operations of our 60-bed facility in Marlton, New Jersey, and our new 24-bed specialty unit in West Philadelphia, Pennsylvania," Kinell said.
About CRI Lifetree CRI Lifetree is a leader in specialized, multitherapeutic early stage research providing innovative solutions, high quality and timely results to sponsors. The company has significant expertise in pain, human abuse liability, psychiatry, neurology and diabetes. CRI Lifetree offers a broad range of Phase I-IV services and rapid access to specific patient populations to meet the requirements of complex clinical research programs. With sites in Marlton, N.J., Philadelphia and Salt Lake City, the company conducts inpatient and outpatient clinical research in special populations and healthy volunteers. For additional information, visit www.crilifetree.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 19, 2012|
|Previous Article:||Finedining Announces Shares Accepted Through Voluntary Takeover Offer as of Sept. 19.|
|Next Article:||PrecisionIR Announces New Integrated Marketing Platform.|